期刊文献+

多重荧光原位杂交检测多发性骨髓瘤复杂核型异常 被引量:1

Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations of multiple myeloma
下载PDF
导出
摘要 目的探讨多重荧光原位杂交(MFISH)技术在多发性骨髓瘤(MM)复杂核型异常(CCAs)检测中的价值。方法对5例常规R显带具有CCAs的MM患者应用MFISH确定复杂染色体的重排及标记染色体的组成。结果明确了常规核型(CC)分析中的所有异常,共检出20种结构异常,其中缺失2种,易位18种,均为不平衡易位。最常累及的为14号染色体、1q的不平衡易位及6号染色体。结论对伴有CCAs的MM患者,MFISH技术可以明确CC分析中复杂染色体异常,并发现和纠正CC分析中漏检及误检的异常,为MM的染色体异常研究提供了一种理想的方法。 Objective To evaluate the technique of multiplex fluorescence in situ hybridization (M-FISH) in the detection of the complex chromosomal aberrations (CCAs) in multiple myeloma (MM). Methods M-FISH was used in five MM patients with CCAs detected by R-banding to refine complex chromosomal rearrangements arid the constitute of marker chromosomes. Results Twenty kinds of structural rearrangements were detected by M-FISH including 2 kinds of deletions, 18 kinds of translocations which were all imbalanced rearrangements. In addition, chromosomes 14, 6 and lq rearrangements were the most frequently involved aberrations. Conclusion M-FISH could refine CCAs of MM patients, find or correct the missed or misidentified abnormalities analysed by conventional cytogenetics. It provides an ideal method for the research of chromosomal aberrations in MM.
出处 《江苏医药》 CAS CSCD 北大核心 2006年第4期304-306,F0002,共4页 Jiangsu Medical Journal
基金 江苏省"135"重点人才基金(RC2002044) 江苏省"135"重点学科开放课题(135XY0201) 卫生部科研课题(WKJ2005205) 南京医科大学科研基金(NY0162)
关键词 多发性骨髓瘤 多重荧光原位杂交 复杂染色体异常 Multiple myeloma Multiplex fluorescence in situ bybridization Complex chromosomal aberrations
  • 相关文献

参考文献9

  • 1葛峥,李建勇.13号染色体缺失与多发性骨髓瘤[J].中华血液学杂志,2003,24(4):219-221. 被引量:16
  • 2Avet-Loiseau H,Li JY,Facon T,et al.High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q23) in patients with plasma cell malignancies.Cancer Res,1998,58:5640-5645. 被引量:1
  • 3Sawyer JR,Lukacs JL,Munshi N,et al.Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping.Blood,1998,92:4269-4278. 被引量:1
  • 4Sawyer JR,Lukacs JL,Thomas EL,et al.Multicolor spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.Br J Haematol,2001,112:167-174. 被引量:1
  • 5Harrison CJ,Mazzullo H,Cheung KL,et al.Cytogenetics of multiple myeloma:interpretation of fluorescence in situ hybridization results.Br J Haematol,2003,120:944-952. 被引量:1
  • 6张之南主编..血液病诊断及疗效标准 第2版[M].北京:科学出版社,1998:434.
  • 7ISCN(1995):An International System for Human Cytogenetic Normenclature,Mitelman F(ed);S.Karger,Basel,1995. 被引量:1
  • 8Yuan BZ,Miller MJ,Keek CL,et al.Cloning characterization and chromosomal localization of a gene frequently deleted in human liver cancer(DLC-1) homologous ratuRhoGAP.Cancer Res,1998,58:2196-2199. 被引量:1
  • 9Ishii H,Baffa R,Numata SI,et al.The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein and its expression is altered in multiple human tumors.Proc Nat Acad Sci USA,1999,6:3928-3933. 被引量:1

二级参考文献1

  • 1N. Worel,H. Greinix,J. Ackermann,H. Kaufmann,E. Urbauer,P. H?cker,H. Gisslinger,K. Lechner,P. Kalhs,J. Drach. Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma[J] 2001,Annals of Hematology(6):345~348 被引量:1

共引文献15

同被引文献26

  • 1秦尤文,魏道林,王椿,颜式可,高彦荣,蔡琦.多发性骨髓瘤的改良细胞遗传学分析[J].中华医学遗传学杂志,2006,23(2):213-215. 被引量:6
  • 2Tinguely M, Jenni B, Reineke T, et al. Chromosomal translocations t ( 4 ; 14 ), t (11 ; 14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays. Am J Surg Pathol,2007,31(5) :690-696. 被引量:1
  • 3Akalin I, Kutlay NY, Ilhan O,et al. Novel chromosomal translocations in multiple myeloma: t(13;16)(q14;q24) and t(1; 15)(q10; q26). Int J Lab Hematol,2007,29(3):215-220. 被引量:1
  • 4Herndndez JM, Gutierrez NC, Almeida J, et al. IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases. Br J Haematol,1998,103(1) :163-167. 被引量:1
  • 5Nilsson T, Lenhoff S, Turesson I, et al. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation. Eur J Haematol,2002,68(6) :345-353. 被引量:1
  • 6Cremer FW, Kartal M, Hose D, et al. High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by muhiprobe interphase FISH. Cancer Genet Cytogenet, 2005, 161 (2):116-124. 被引量:1
  • 7Schmidt-Wolf IG, Glasmacher A, Hahn Ast C, et al. Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance. Cancer Genet Cytogenet, 2006,167 (1): 20-25. 被引量:1
  • 8Dewald GW, Therneau T, Larson D,et al. Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. Blood, 2005, 106 (10) : 3553-3558. 被引量:1
  • 9Koren-Michowitz M, Hardan l, Berghoff J, et al. Chromosome 13q deletion and IgH abnormalities may be both masked by neartetraploidy in a high proportion of muhiple myeloma patients: a combined morphology and I-FISH analysis. Cancer Lett,2007,255 (2) :307-314. 被引量:1
  • 10Hardan I, Rothman R, Gelibter A, et al. Determination of chro mosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hy bridization analysis. Exp Hematol,2004,32(3):254-260. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部